Robert Bucki
Impact in
- Microbiology top 0.1%
- Antimicrobial Peptides and Activities
- Cell Biology top 1%
- Cellular Mechanics and Interactions
Papers in
- Microbiology 60
- Antimicrobial Peptides and Activities 58
- Cell Biology 25
- Cellular Mechanics and Interactions 22
- Co-authors
- Paul A. Janmey (65 shared papers)Ewelina Piktel (82 shared papers)Paul B. Savage (48 shared papers)Katarzyna Niemirowicz (30 shared papers)Fitzroy J. Byfield (22 shared papers)Piotr Deptuła (47 shared papers)Bonita Durnaś (43 shared papers)Tomasz Wollny (23 shared papers)
- Journals
- International Journal of Molecular Sciences (17 papers)Pathogens (9 papers)International Journal of Nanomedicine (8 papers)Scientific Reports (6 papers)Biochemistry (5 papers)
- Partner nations
- PolandUnited StatesFrance
In The Last Decade
Robert Bucki
203 papers receiving 6.7k citations
Robert Bucki's Hit Papers
Peers
Comparison fields: 5 of 131
- Microbiology 1.6k
- Cell Biology 749
- Biomaterials 546
- Molecular Medicine 231
- Drug Discovery 8
Countries citing papers authored by Robert Bucki
This map shows the geographic impact of Robert Bucki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bucki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bucki more than expected).
Fields of papers citing papers by Robert Bucki
This network shows the impact of papers produced by Robert Bucki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bucki. The network helps show where Robert Bucki may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Bucki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 212 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment Hit paper breakdown → | 2021 | 272 |
| 2 | 2011 | 230 | |
| 3 | 2008 | 193 | |
| 4 | 2010 | 190 | |
| 5 | 2014 | 172 | |
| 6 | 2016 | 145 | |
| 7 | 2023 | 123 | |
| 8 | 2018 | 114 | |
| 9 | 2003 | 108 | |
| 10 | 2013 | 107 | |
| 11 | 2019 | 105 | |
| 12 | 2001 | 101 | |
| 13 | 2021 | 100 | |
| 14 | 2015 | 96 | |
| 15 | 2005 | 93 | |
| 16 | 2007 | 93 | |
| 17 | 2007 | 91 | |
| 18 | 2008 | 90 | |
| 19 | 2018 | 90 | |
| 20 | 2019 | 86 |
About Robert Bucki
Robert Bucki is a scholar working on Microbiology, Cell Biology, Biomaterials, Molecular Biology and Infectious Diseases, having authored 212 papers that have together received 6.8k indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (58 papers), Cellular Mechanics and Interactions (22 papers), Nanoparticles: synthesis and applications (21 papers), Nanoparticle-Based Drug Delivery (16 papers), Antimicrobial agents and applications (15 papers), Bacterial biofilms and quorum sensing (11 papers), Helicobacter pylori-related gastroenterology studies (10 papers) and Antifungal resistance and susceptibility (9 papers). The work is most often cited by research in Microbiology (1.6k citations), Cell Biology (749 citations), Biomaterials (546 citations), Molecular Medicine (231 citations) and Drug Discovery (8 citations). Robert Bucki has collaborated with scholars based in Poland, United States and France. Frequent co-authors include Paul A. Janmey, Ewelina Piktel, Paul B. Savage, Katarzyna Niemirowicz, Fitzroy J. Byfield, Piotr Deptuła, Bonita Durnaś, Tomasz Wollny, Alina Kułakowska and Marzena Wątek. Their work appears in journals such as International Journal of Molecular Sciences, Pathogens, International Journal of Nanomedicine, Scientific Reports and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.